Catalyst Wire Dossier Catalyst Wire Dossier

RSV mRNA investigational vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSV mRNA investigational vaccine, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years [Phase 1]

See pricing